Association and Additive Risk of Respiratory and Viral Response Baseline Variables With Mortality in Therapeutics for Inpatients With COVID-19 (TICO) Platform Randomized Clinical Trial (RCT) Participants

D93. CLINICAL AND TRANSLATIONAL STUDIES OF COVID-19 CRITICAL ILLNESS Pub Date : 2023-05-01 DOI:10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a6556

N. Aggarwal, J. Nordwall, T. Der, N. Eriobu, A. Ginde, J. Hayanga, H. Highbarger, J. Lundgren, S. Laverdure, S. Pett, A. Phillips, A. Rogers, U. Sandkovsky, K. Shaw-Saliba, C. Reilly, ACTIV-3 / TICO, Strive

引用次数: 0

查看原文本刊更多论文

COVID-19住院患者(TICO)平台随机临床试验(RCT)参与者治疗方法中呼吸和病毒反应基线变量与死亡率的关联和附加风险

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

D93. CLINICAL AND TRANSLATIONAL STUDIES OF COVID-19 CRITICAL ILLNESS

自引率

0.00%

发文量